Indian Pharmacopoeia 2014 Pdf 46
Miina Hunker
After reviewing each application, the PDG agreed by consensus to start the pilot phase with the IPC, the only applicant that met all the requirements in the entry criteria for the pilot. The PDG would like to thank the other applicants for their interest in the pilot and will remain in touch on potential collaborative opportunities in the future with the aim of achieving greater convergence of global pharmacopoeial standards. This includes continuing to share PDG publications (i.e. draft texts for public consultation and final sign-off texts) with non-PDG pharmacopoeias in order to support convergence of these texts beyond the PDG. The PDG also continues to welcome comments from other pharmacopoeias on its draft texts.
The US Pharmacopeia (USP) announced on Oct. 5, 2023 that the Indian Pharmacopoeia Commission (IPC) is now a member of the Pharmacopoeial Discussion Group (PDG). The PDG was established by the European Pharmacopoeia Commission (Ph. Eur.), Japanese Pharmacopoeia (JP), and USP, with observation by The World Health Organization (WHO). The PDG facilitates harmonization of pharmacopoeial standards globally with a consistent level of science to reduce the burden on manufacturers to satisfy multiple requirements.
The traditional pharmacopoeia of the Seri Indians of Sonora, Mexico, involves approximately 95 species of plants in 80 genera, 15 animal species, and one kind of clay. In contrast only 75 species of plants were utilized for food. Medicinal teas are prepared from 63 plant species. Plants with aromatic foliage are especially esteemed. The predilection for watery preparations seems to be related to the commonplace water deficit in a very hot and arid environment.
Although a shaman was frequently involved in curing sickness, he generally did not administer medicines. For the most part, traditional Seri medicine has been a highly individual affair. The few mixtures are relatively simple preparations. The absence of complicated formulae encourages self-administered medicines and the information can readily diffuse through the culture. Because it is an individual-oriented and non-professionally administered pharmacopoeia, each individual may not know every remedy. To the Seri, origin and use of their various remedies appear to be highly pragmatic, often based on trial and error, i.e., it is effective.
India has joined a global effort to harmonise various pharmacopoeias, which are lists of medicinal drugs with their effects and directions for use, the government said in a statement on Tuesday. A standardised pharmacopoeia will make it easier for drugmakers to adhere to procedural norms for multiple markets.
The Indian Pharmacopoeia Commission has officially joined as a member in the Pharmacopoeial Discussion Group (PDG), which was established in 1989to harmonise pharmacopeial standards in the world, the statement said.
The move will establish IP as progressive pharmacopoeia that designs drug quality standards at par with global standards, according to the health ministry. Application of these standards will lead to production of world-class pharmaceutical products for domestic and export markets, it said.
It will also help the local commission to collaborate and harmonise pharmacopoeial standards with other major regulatory or standard setting authorities, leading potentially to improve the acceptance of Indian medicinal products in global markets, as they adhere to globally recognized quality standards. In the long run, it will reduce trade barriers.
The Indian commission will also benefit from the exchange of information and best practices with other members, helping India in aligning its regulatory processes and practices with global standards. It will contribute to the global effort to ensure the safety and efficacy of marketed pharmaceutical products having a direct impact on public health worldwide, as it would help to prevent the circulation of substandard or counterfeit drugs.
Background: This article emphasise on the Journey of Indian Pharmacopoeia and its parent organisation, the Indian Pharmacopoeia Commission (IPC) as setting up standards for maintaining the efficacy and quality of drugs used for the treatment of diseases prevailing in India. This study attempts to explore Indian Pharmacopoeial growth and general awareness among the scientists, research scholars, drug manufacturers, testing laboratories, healthcare professionals and other stakeholders for their compliance and usage. This article describe the functions of IP Commission such as revision and publication of the Indian Pharmacopoeia, addendum, National formulary of India on a regular basis also providing IP Reference Substances and professional training to the stakeholders on pertaining the Pharmacopoeial work.
Objectives of the Study: The objectives of the study are as follows:
i. To increase awareness about the Indian Pharmacopoeia (IP) and National Formulary of India (NFI) among the stakeholders; ii. To highlight the Pharmacopoeial importance in India; iii. To discuss landscape for safety and efficacy of the medicines; iv. To explore the journey of the Indian Pharmacopoeia (IP) and National Formulary of India (NFI).
Research Methodology: This article has been brought out on the basis of evaluation of pharmacopoeial publications and recent literature published online relevant to the drug and pharmaceuticals and it is a kind of descriptive study. There is a shortage of previous similar studies observed on Pharmacopoeial importance and its compliance. It is an attempt being made to understand the drug standardization for rational use of medicine in India.
This document provides an introduction to Indian pharmacopoeias and their history and development. It discusses that the Indian Pharmacopoeia is the official book that contains standards for drugs and related substances in India. It must be complied with by manufacturers. The document outlines the various editions of the Indian Pharmacopoeia published since 1955 and describes the typical contents and structure of monographs in the publications. It also provides a brief introduction to the National Formulary of India and its editions.Read less
The IP is published by the Indian Pharmacopoeia Commission (IPC) on behalf of the Ministry of Health and Family Welfare. It prescribes the official standards for drugs produced and/or marketed in India and thus contributes to the control and assurance of the quality of the medicines. The standards of the IP are authoritative and legally enforceable. It intends to help in the licensing of manufacturing, inspection and distribution of medicines in our country.
IP 2022 contains a total of 92 new monographs, including 60 chemicals, 21 vitamins, minerals, Amino acids, fatty acids etc., 3 biotechnology-derived therapeutic products, 4 human vaccines, 2 blood and blood-related products, 2 herbs and herbal-related products, and 7 phytopharmaceutical ingredient category monographs. This has led to the total number of 3,152 monographs in the current edition of IP. In addition, 12 new general chapters have been introduced. Several monographs and general chapters have also been revised to update them as per current global requirements and to harmonise with other pharmacopoeias. The harmonisation of standards with global standards is expected to help IP getting recognised and accepted in foreign countries.
We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.
In recent past (May 2022), regulatory authorities asked mfg to perform nitrosamine testing. But limited analytical testing capabilities and cost aspects acted as big barriers for mfg specifically small and medium mfg selling products locally. Even many state regulators laboratories currently lack required analytical capabilities. But nitrosamine impurities inclusion for sartan APIs monographs and voluntary for other drugs in Indian Pharmacopoeia 2022, regulators hinted for eventual compliance requirements in coming years for indian maket.
The Pharmacopoeial Discussion Group (PDG) has inducted the Indian Pharmacopoeia Commission (IPC) as a permanent group member, earlier this month. The World Health Organization (WHO) continues to serve as an observer of the group.
Typically, pharmacopoeia in the modern parlance is defined as a book that contains directions for identification of compound medicines and published by an authority (Government) or a medical or pharmaceutical society.
Lakshmi Narain College of Pharmacy Bhopal has organized Workshop on \"Quality evaluation of Tablets as per Indian pharmacopoeia\" on 6th feb, 2023. The students of B.pharma 8th and 6th sem has participated in workshop with full zeal and vigour. The entire event were coordinated by Dr. Abhilasha Singh and Ms.Richa Verma under the guidance of convener Dr Parul Mehta .\nThe participants have gained immense knowledge after this workshop and are excited for more upcoming events.
b37509886e